000 01314 a2200409 4500
005 20250516022945.0
264 0 _c20110609
008 201106s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2011.6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBreccia, M
245 0 0 _a5'-azacitidine in myelodysplastic syndromes with inversion of chromosome 3.
_h[electronic resource]
260 _bLeukemia
_cApr 2011
300 _a736-7 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntimetabolites, Antineoplastic
_xtherapeutic use
650 0 4 _aAzacitidine
_xtherapeutic use
650 0 4 _aChromosome Inversion
_xgenetics
650 0 4 _aChromosomes, Human, Pair 3
_xgenetics
650 0 4 _aHumans
650 0 4 _aIn Situ Hybridization, Fluorescence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aCannella, L
700 1 _aSantopietro, M
700 1 _aLoglisci, G
700 1 _aFederico, V
700 1 _aSalaroli, A
700 1 _aNanni, M
700 1 _aMancini, M
700 1 _aAlimena, G
773 0 _tLeukemia
_gvol. 25
_gno. 4
_gp. 736-7
856 4 0 _uhttps://doi.org/10.1038/leu.2011.6
_zAvailable from publisher's website
999 _c20571996
_d20571996